DNA Repair in Cancer Therapy 2012
DOI: 10.1016/b978-0-12-384999-1.10012-5
|View full text |Cite
|
Sign up to set email alerts
|

Personalized Cancer Medicine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2014
2014
2015
2015

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 206 publications
0
1
0
Order By: Relevance
“…Moreover, APE1 polymorphisms are associated with the disposition to cancer. , APE1 expression is upregulated or dysregulated in many human cancers. In general, APE1 overexpression is associated with many adverse effects, including resistance to therapy, prolonged therapeutic response, and lower survival rates. , DNA repair and redox regulatory activities of APE1 affect various signaling pathways, suggesting that cancer cells may be addicted to APE1 functions for survival . Many aspects of APE1 as outlined above make it a well-justified target in cancer for development of inhibitors as anticancer drugs.…”
mentioning
confidence: 99%
“…Moreover, APE1 polymorphisms are associated with the disposition to cancer. , APE1 expression is upregulated or dysregulated in many human cancers. In general, APE1 overexpression is associated with many adverse effects, including resistance to therapy, prolonged therapeutic response, and lower survival rates. , DNA repair and redox regulatory activities of APE1 affect various signaling pathways, suggesting that cancer cells may be addicted to APE1 functions for survival . Many aspects of APE1 as outlined above make it a well-justified target in cancer for development of inhibitors as anticancer drugs.…”
mentioning
confidence: 99%